Medicines / Astrazeneca Pharma India / Fasenra
FasenraBenralizumab
Fasenra is marketed by Astrazeneca Pharma India. 1 pack on NPPA's price list for July 2026, containing Benralizumab.
- Packs listed
- 1
- Lowest MRP
- ₹225,000
- Per unit
- ₹225,000
- Price-controlled packs
- 0 of 1
- Dosage forms
- 1
Packs and prices
- ₹225,000Fasenra 30 mg Injection 1 mlBenralizumab Injection 30 mg · ₹225,000 per ml
The company
Astrazeneca Pharma India has 57 packs on the price list. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.